Hancock Jaffe Laboratories Inc Bennfentes tulajdonlás

Mi az Hancock Jaffe Laboratories Inc Bennfentes tulajdonlás?

A Bennfentes tulajdonlás az Hancock Jaffe Laboratories Inc - 12.67%

Mi a Bennfentes tulajdonlás meghatározása?



A bennfentes tulajdonjog kiszámítása a bennfentesek tulajdonában lévő részvények (részvényesek, akik a vállalat több mint 5% -át, vagy a vállalat tisztségviselőjét vagy igazgatóját birtokolják) teljes létszámával, osztva a teljes részvénykivonással.

A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.

A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.

Bennfentes tulajdonlás a Health Care szektor a NASDAQ-on cégekben a Hancock Jaffe Laboratories Inc -hoz képest

Mit csinál Hancock Jaffe Laboratories Inc?

Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.

bennfentes tulajdonlás -hoz hasonló cégek Hancock Jaffe Laboratories Inc